Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome

Neuroscience

Volumn 231, Issue , 2013, Pages 195-205

  McLeod, F ^a   Ganley, R ^a   Williams, L ^a   Selfridge, J ^b   Bird, A ^b   Cobb, S R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Epilepsy; Excitability; Gamma oscillations; MECP2; Network; Rett Syndrome

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; FEMALE; GENOTYPE; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RETT SYNDROME; SCORING SYSTEM; SEIZURE; SEIZURE THRESHOLD; SYNAPTIC TRANSMISSION;

4-AMINOPYRIDINE; ANIMALS; BICUCULLINE; BRAIN WAVES; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; GABA-A RECEPTOR ANTAGONISTS; HIPPOCAMPUS; KAINIC ACID; METHYL-CPG-BINDING PROTEIN 2; MICE; NERVE NET; NEURONS; POTASSIUM CHANNEL BLOCKERS; RETT SYNDROME; SEIZURES;

EID: 84872292990     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.058     Document Type: Article

References (43)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
2. Anderson W.W., Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods 2001, 108:71-83.
3. Asaka Y., Jugloff D.G., Zhang L., Eubanks J.H., Fitzsimonds R.M. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 2006, 21:217-227.
4. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 2009, 514:240-258.
5. Calfa G., Hablitz J.J., Pozzo-Miller L. Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol 2011, 105:1768-1784.
6. Cardoza B., Clarke A., Wilcox J., Gibbon F., Smith P.E., Archer H., Hryniewiecka-Jaworska A., Kerr M. Epilepsy in Rett syndrome: association between phenotype and genotype, and implications for practice. Seizure 2011, 20:646-649.
7. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
8. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., Ekker M., Rubenstein J.L., Noebels J.L., Rosenmund C., Zoghbi H.Y. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
9. Chao H.T., Zoghbi H.Y., Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56:58-65.
10. Chapleau C.A., Calfa G.D., Lane M.C., Albertson A.J., Larimore J.L., Kudo S., Armstrong D.L., Percy A.K., Pozzo-Miller L. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis 2009, 35:219-233.
11. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27:327-331.
12. Cobb S., Guy J., Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans 2010, 38:498-506.
13. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., David Sweatt J., Zoghbi H.Y. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 2004, 13:2679-2689.
14. D'Cruz J.A., Wu C., Zahid T., El-Hayek Y., Zhang L., Eubanks J.H. Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol Dis 2010, 38:8-16.
15. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 2005, 102:12560-12565.
16. Fisahn A., Contractor A., Traub R.D., Buhl E.H., Heinemann S.F., McBain C.J. Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations. J Neurosci 2004, 24:9658-9668.
17. Gadalla K.K., Bailey M.E., Cobb S.R. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Biochem J 2011, 439:1-14.
18. Gadalla KKE, Bailey MES, Spike RC, Ross P, Woodard KT, Kalburgi SN, Bachaboina L, Deng JV, West AE, Samulski RJ, Gray SJ, Cobb SR (2012) Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol Ther, in press. [Epub ahead of print]. doi:10.1038/mt.2012.200.
19. Glaze D.G. Neurophysiology of Rett syndrome. J Child Neurol 2005, 20:740-746.
20. Glaze D.G., Percy A.K., Skinner S., Motil K.J., Neul J.L., Barrish J.O., Lane J.B., Geerts S.P., Annese F., Graham J., McNair L., Lee H.S. Epilepsy and the natural history of Rett syndrome. Neurology 2010, 74:909-912.
21. Goffin D., Allen M., Zhang L., Amorim M., Wang I.T., Reyes A.R., Mercado-Berton A., Ong C., Cohen S., Hu L., Blendy J.A., Carlson G.C., Siegel S.J., Greenberg M.E., Zhou Z. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci 2012, 15:274-283.
22. Guy J., Cheval H., Selfridge J., Bird A. The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 2011, 27:631-652.
23. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
24. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27:322-326.
25. Hagberg B., Hanefeld F., Percy A., Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett syndrome clinical criteria consensus panel satellite to European paediatric neurology society meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 2002, 6:293-297.
26. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 2000, 12:3239-3249.
27. Kim H.J., Kim S.H., Kim H.D., Lee J.S., Lee Y.M., Koo K.Y., Kang H.C. Genetic and epileptic features in Rett syndrome. Yonsei Med J 2012, 53:495-500.
28. Medrihan L., Tantalaki E., Aramuni G., Sargsyan V., Dudanova I., Missler M., Zhang W. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 2008, 99:112-121.
29. Nelson E.D., Kavalali E.T., Monteggia L.M. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol 2006, 16:710-716.
30. Neul J.L., Kaufmann W.E., Glaze D.G., Christodoulou J., Clarke A.J., Bahi-Buisson N., Leonard H., Bailey M.E., Schanen N.C., Zappella M., Renieri A., Huppke P., Percy A.K. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010, 68:944-950.
31. Ramocki M.B., Peters S.U., Tavyev Y.J., Zhang F., Carvalho C.M., Schaaf C.P., Richman R., Fang P., Glaze D.G., Lupski J.R., Zoghbi H.Y. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 2009, 66:771-782.
32. Robinson L., Guy J., McKay L., Brockett E., Spike R., Selfridge J., De Sousa D., Merusi C., Riedel G., Bird A., Cobb S.R. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 2012, 135:2699-2710.
33. Roshan-Milani S., Ferrigan L., Khoshnood M.J., Davies C.H., Cobb S.R. Regulation of epileptiform activity in hippocampus by nicotinic acetylcholine receptor activation. Epilepsy Res 2003, 56:51-65.
34. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
35. Steffenburg U., Hagberg G., Hagberg B. Epilepsy in a representative series of Rett syndrome. Acta Paediatr 2001, 90:34-39.
36. Traub R.D., Jefferys J.G. Are there unifying principles underlying the generation of epileptic afterdischarges in vitro?. Prog Brain Res 1994, 102:383-394.
37. Traub R.D., Spruston N., Soltesz I., Konnerth A., Whittington M.A., Jefferys G.R. Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity. Prog Neurobiol 1998, 55:563-575.
38. Uhlhaas P.J., Pipa G., Neuenschwander S., Wibral M., Singer W. A new look at gamma? High- (>60Hz) gamma-band activity in cortical networks: function, mechanisms and impairment. Prog Biophys Mol Biol 2011, 105:14-28.
39. Weng S.M., McLeod F., Bailey M.E., Cobb S.R. Synaptic plasticity deficits in an experimental model of Rett syndrome: long term potentiation saturation and its pharmacological reversal. Neuroscience 2011, 180:314-321.
40. Whittington M.A., Cunningham M.O., LeBeau F.E., Racca C., Traub R.D. Multiple origins of the cortical gamma rhythm. Dev Neurobiol 2011, 71:92-106.
41. Wood L., Gray N.W., Zhou Z., Greenberg M.E., Shepherd G.M. Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J Neurosci 2009, 29:12440-12448.
42. Zhang L., He J., Jugloff D.G., Eubanks J.H. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 2008, 18:294-309.
43. Zhang Z.W., Zak J.D., Liu H. MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 2010, 103:2470-2481.